Takip et
Wilfried Eberhardt
Wilfried Eberhardt
Innere Klinik (Tumorforschung), University of Duisburg-Essen
uni-duisburg-essen.de üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer
J Brahmer, KL Reckamp, P Baas, L Crinò, WEE Eberhardt, ...
New England Journal of Medicine 373 (2), 123-135, 2015
92452015
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
45272016
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
TIALCTC Group
N Engl J Med 350, 351-360, 2004
3067*2004
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
R Pirker, JR Pereira, A Szczesna, J von Pawel, M Krzakowski, R Ramlau, ...
The Lancet 373 (9674), 1525-1531, 2009
18392009
Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials …
L Horn, DR Spigel, EE Vokes, E Holgado, N Ready, M Steins, ...
Journal of clinical oncology 35 (35), 3924-3933, 2017
9262017
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 …
R Pirker, JR Pereira, J Von Pawel, M Krzakowski, R Ramlau, K Park, ...
The lancet oncology 13 (1), 33-42, 2012
7002012
The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth …
WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ...
Journal of Thoracic Oncology 11 (8), 1204-1223, 2016
6852016
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J Vansteenkiste, D De Ruysscher, WEE Eberhardt, E Lim, S Senan, ...
Annals of oncology 24, vi89-vi98, 2013
6642013
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ...
Annals of Oncology 25 (8), 1462-1474, 2014
5852014
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
C Butts, MA Socinski, PL Mitchell, N Thatcher, L Havel, M Krzakowski, ...
The lancet oncology 15 (1), 59-68, 2014
5802014
The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer
WEE Eberhardt, A Mitchell, J Crowley, H Kondo, YT Kim, A Turrisi III, ...
Journal of thoracic oncology 10 (11), 1515-1522, 2015
5682015
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
H Borghaei, S Gettinger, EE Vokes, LQM Chow, MA Burgio, JC Carpeno, ...
Journal of Clinical Oncology 39 (7), 723-733, 2021
5262021
Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non–small-cell lung cancer (RADIANT): A randomized, double-blind, phase III trial
K Kelly, NK Altorki, WEE Eberhardt, MER O'Brien, DR Spigel, L Crinò, ...
Journal of Clinical Oncology 33 (34), 4007-4014, 2015
5232015
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial
RS Herbst, Y Sun, WEE Eberhardt, P Germonpré, N Saijo, C Zhou, ...
The lancet oncology 11 (7), 619-626, 2010
5012010
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ...
Annals of Oncology 26 (8), 1573-1588, 2015
494*2015
International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions. International Association for …
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
J Thorac Oncol 11 (1), 39-51, 2016
4692016
The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer
K Chansky, FC Detterbeck, AG Nicholson, VW Rusch, E Vallières, ...
Journal of Thoracic Oncology 12 (7), 1109-1121, 2017
4552017
The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung …
AG Nicholson, K Chansky, J Crowley, R Beyruti, K Kubota, A Turrisi, ...
Journal of Thoracic Oncology 11 (3), 300-311, 2016
4242016
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small …
W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, ...
Journal of clinical oncology 16 (2), 622-634, 1998
4101998
Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA (N2) and selected IIIB non–small-cell lung cancer after …
WEE Eberhardt, C Pöttgen, TC Gauler, G Friedel, S Veit, V Heinrich, ...
Journal of Clinical Oncology 33 (35), 4194-4201, 2015
3922015
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20